Evidence map›Paper›PMID 21872440›Full record

ReviewEpilepsy research2012

The effects of the ketogenic diet on behavior and cognition.

Tove Hallböök, Sunggoan Ji, Stuart Maudsley, Bronwen Martin

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in Epilepsy research, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06091163 (A Randomised Controlled Trial Evaluating the Efficacy and Mechanisms of a Ketogenic Diet as an Adjunctive Treatment for People With Treatment-resistant Depression), which is not on this map. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06091163 nacompletednot on this mapstarted 2024, after this paper: background citation

A Randomised Controlled Trial Evaluating the Efficacy and Mechanisms of a Ketogenic Diet as an Adjunctive Treatment for People With Treatment-resistant Depression

TypeinterventionalSponsorUniversity of OxfordRan2024 to 2024Enrolled88ConditionsTreatment Resistant Depression, Depression, Mental Illness, Mental DisorderArmsKetogenic Diet, Phytonutrient Diet
3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it, 89 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Ketogenic diet experience at Ondokuz Mayıs University.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Tove HallböökQueen Silvia Children's Hospital, Sahlgrenska University, Gothenburg, Sweden. tove.hallbook@telia.com
Sunggoan Ji
Stuart Maudsley
Bronwen Martin
National Institute on Aging · USSahlgrenska University Hospital · SE

Funding

Oxidative stresses and complex proteomic responses to themZIAAG000325 · NIA · NATIONAL INSTITUTE ON AGING · PI MAUDSLEY, STUART · 2009 to 2012
$1.4M
Age and pathology-induced alteration of G protein-coupled receptor signalingZIAAG000318 · NIA · NATIONAL INSTITUTE ON AGING · PI MAUDSLEY, STUART · 2009 to 2012
$1.0M
Innate intelligence and prognostication for prevention of neurodegenerationZIAAG000319 · NIA · NATIONAL INSTITUTE ON AGING · PI MAUDSLEY, STUART · 2009 to 2012
$1.0M
Cognitive function and metabolic controlZIAAG000917 · NIA · NATIONAL INSTITUTE ON AGING · PI MARTIN, BRONWEN · 2010 to 2012
$901k
A systems biology approach for assessing metabolic alterations across life-spanZIAAG000915 · NIA · NATIONAL INSTITUTE ON AGING · PI MARTIN, BRONWEN · 2010 to 2012
$548k
Development of novel methods for systems biology of metabolism and agingZIAAG000916 · NIA · NATIONAL INSTITUTE ON AGING · PI MARTIN, BRONWEN · 2010 to 2012
$518k
Intramural NIH HHS ZIA AG000917
6 · The paper itself

Abstract

Multiple forms of the ketogenic diet (KD) have been successfully used to treat drug-resistant epilepsy, however its mainstream use as a first-line therapy is still limited. Further investigation into its clinical efficacy as well as the molecular basis of activity is likely to assist in the reversal of any resistance to its implementation. In this review we shall attempt to elucidate the current state of experimental and clinical data concerning the neuroprotective and cognitive effects of the KD in both humans and animals. Generally, it has been shown by many research groups that effective implementation of KD exerts strong neuroprotective effects with respect to social behavior and cognition. We will also elucidate the role of KD in the interesting relationship between sleep, epilepsy and memory. Currently available evidence also indicates that, under appropriate control, and with further studies investigating any potential long-term side effects, the KD is also a relatively safe intervention, especially when compared to traditional anti-epileptic pharmacotherapeutics. In addition, due to its neuroprotective capacity, the KD may also hold potential benefit for the treatment of other neurological or neurodegenerative disorders.

Indexed as

Diet, KetogenicAnimalsCognitionEpilepsyHumansMemoryNeurodegenerative DiseasesSleep

Identifiers

PMID21872440
PMCPMC4112040
OpenAlexW2135482827

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.